Vaccine for use in the prophylaxis and/or treatment of a disease
Abstract:
The present invention relates to an adenoviral vector capable of encoding a virus-like particle (VLP), said VLP displaying an inactive immune-suppressive domain (ISD). The vaccine of the invention shows an improved immune response from either of both of the response pathways initiated by CD4 T cells or CD8 T cells.
Public/Granted literature
Information query
Patent Agency Ranking
0/0